Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
4.370
-0.270 (-5.82%)
At close: Feb 18, 2026, 4:00 PM EST
4.390
+0.020 (0.46%)
After-hours: Feb 18, 2026, 7:32 PM EST
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.37 billion as of February 18, 2026. Its market cap has decreased by -63.37% in one year.
Market Cap
1.37B
Enterprise Value
2.61B
1-Year Change
-63.37%
Ranking
Category
Stock Price
$4.37
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.37B, an increase of 348.95%. That is a compound annual growth rate of 32.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 1.37B | -14.81% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 2.12B |
| Perrigo Company | 1.99B |
| Harrow | 1.87B |
| BioCryst Pharmaceuticals | 1.72B |
| ANI Pharmaceuticals | 1.65B |
| Amylyx Pharmaceuticals | 1.55B |
| Collegium Pharmaceutical | 1.46B |
| Amphastar Pharmaceuticals | 1.31B |